These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18368266)

  • 1. [Candidemia in a Brazilian tertiary care hospital: incidence, frequency of different species, risk factors and antifungal susceptibility].
    França JC; Ribeiro CE; Queiroz-Telles Fd
    Rev Soc Bras Med Trop; 2008; 41(1):23-8. PubMed ID: 18368266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
    Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
    Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
    Durán MT; Velasco D; Canle D; Moure R; Villanueva R
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of candidemia: a one-year prospective observational study in the west of France].
    Talarmin JP; Boutoille D; Tattevin P; Dargère S; Weinbreck P; Ansart S; Chennebault JM; Hutin P; Léautez-Nainville S; Gay-Andrieu F; Raffi F;
    Med Mal Infect; 2009 Dec; 39(12):877-85. PubMed ID: 19346088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
    Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
    J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
    Pfaller MA; Jones RN; Doern GV; Sader HS; Hollis RJ; Messer SA
    J Clin Microbiol; 1998 Jul; 36(7):1886-9. PubMed ID: 9650930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.
    Aquino VR; Lunardi LW; Goldani LZ; Barth AL
    Braz J Infect Dis; 2005 Oct; 9(5):411-8. PubMed ID: 16410893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.
    Almirante B; Rodríguez D; Park BJ; Cuenca-Estrella M; Planes AM; Almela M; Mensa J; Sanchez F; Ayats J; Gimenez M; Saballs P; Fridkin SK; Morgan J; Rodriguez-Tudela JL; Warnock DW; Pahissa A;
    J Clin Microbiol; 2005 Apr; 43(4):1829-35. PubMed ID: 15815004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
    Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
    Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital.
    Luzzati R; Amalfitano G; Lazzarini L; Soldani F; Bellino S; Solbiati M; Danzi MC; Vento S; Todeschini G; Vivenza C; Concia E
    Eur J Clin Microbiol Infect Dis; 2000 Aug; 19(8):602-7. PubMed ID: 11014622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers.
    Colombo AL; Nucci M; Park BJ; Nouér SA; Arthington-Skaggs B; da Matta DA; Warnock D; Morgan J;
    J Clin Microbiol; 2006 Aug; 44(8):2816-23. PubMed ID: 16891497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungemia in the French department of Mayotte, Indian Ocean: A 10 years survey.
    Wankap R; Mogo C; Niang M; Diallo A; Balloy L; Baes L; Collet L; Benoit-Cattin T; Permal S; Guegan H; Gangneux JP
    J Mycol Med; 2021 Mar; 31(1):101081. PubMed ID: 33360730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of candidemia at a Children's hospital, 2002 to 2006.
    Neu N; Malik M; Lunding A; Whittier S; Alba L; Kubin C; Saiman L
    Pediatr Infect Dis J; 2009 Sep; 28(9):806-9. PubMed ID: 19636286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.
    Hajjeh RA; Sofair AN; Harrison LH; Lyon GM; Arthington-Skaggs BA; Mirza SA; Phelan M; Morgan J; Lee-Yang W; Ciblak MA; Benjamin LE; Sanza LT; Huie S; Yeo SF; Brandt ME; Warnock DW
    J Clin Microbiol; 2004 Apr; 42(4):1519-27. PubMed ID: 15070998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
    Passos XS; Costa CR; Araújo CR; Nascimento ES; e Souza LK; Fernandes Ode F; Sales WS; Silva Mdo R
    Mycopathologia; 2007 Mar; 163(3):145-51. PubMed ID: 17334813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil.
    Canela HMS; Cardoso B; Vitali LH; Coelho HC; Martinez R; Ferreira MEDS
    Mycoses; 2018 Jan; 61(1):11-21. PubMed ID: 28940753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain.
    Cisterna R; Ezpeleta G; Telleria O;
    J Clin Microbiol; 2010 Nov; 48(11):4200-6. PubMed ID: 20826636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility.
    Arendrup MC; Fuursted K; Gahrn-Hansen B; Jensen IM; Knudsen JD; Lundgren B; Schønheyder HC; Tvede M
    J Clin Microbiol; 2005 Sep; 43(9):4434-40. PubMed ID: 16145088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.
    Pemán J; Cantón E; Gobernado M;
    Eur J Clin Microbiol Infect Dis; 2005 Jan; 24(1):23-30. PubMed ID: 15619060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.